EUR 23.6
(1.72%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 8.5 Million EUR | -24.91% |
2022 | 11.32 Million EUR | 412.99% |
2021 | 2.2 Million EUR | -69.54% |
2020 | 7.24 Million EUR | -56.83% |
2019 | 16.78 Million EUR | 28.47% |
2018 | 13.06 Million EUR | 1.69% |
2017 | 12.85 Million EUR | -1.93% |
2016 | 13.1 Million EUR | 37.62% |
2015 | 9.52 Million EUR | -65.5% |
2014 | 27.59 Million EUR | 6.22% |
2013 | 25.98 Million EUR | 38.99% |
2012 | 18.69 Million EUR | 21.49% |
2011 | 15.38 Million EUR | 228.5% |
2010 | 4.68 Million EUR | 1856.41% |
2009 | -266.65 Thousand EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 4.78 Million EUR | 0.0% |
2023 Q4 | 8.5 Million EUR | 0.0% |
2023 Q2 | 12.23 Million EUR | 0.0% |
2023 FY | 8.5 Million EUR | -24.91% |
2022 Q2 | 2.56 Million EUR | 0.0% |
2022 Q4 | 11.32 Million EUR | 0.0% |
2022 FY | 11.32 Million EUR | 412.99% |
2021 Q4 | 2.2 Million EUR | 0.0% |
2021 Q2 | 3.5 Million EUR | 0.0% |
2021 FY | 2.2 Million EUR | -69.54% |
2020 Q2 | 11.58 Million EUR | 0.0% |
2020 FY | 7.24 Million EUR | -56.83% |
2020 Q4 | 7.24 Million EUR | 0.0% |
2019 FY | 16.78 Million EUR | 28.47% |
2019 Q4 | 16.78 Million EUR | 0.0% |
2019 Q2 | 14.67 Million EUR | 0.0% |
2018 Q4 | 12.98 Million EUR | 0.0% |
2018 FY | 13.06 Million EUR | 1.69% |
2018 Q2 | 9.69 Million EUR | 0.0% |
2017 Q4 | 12.76 Million EUR | 0.0% |
2017 Q2 | 7.65 Million EUR | 0.0% |
2017 FY | 12.85 Million EUR | -1.93% |
2016 FY | 13.1 Million EUR | 37.62% |
2016 Q2 | 6.31 Million EUR | 0.0% |
2016 Q4 | 13.01 Million EUR | 0.0% |
2015 Q4 | 9.52 Million EUR | 0.0% |
2015 FY | 9.52 Million EUR | -65.5% |
2015 Q2 | 35.86 Million EUR | 0.0% |
2014 Q4 | 27.59 Million EUR | 0.0% |
2014 FY | 27.59 Million EUR | 6.22% |
2014 Q2 | 26.67 Million EUR | 0.0% |
2013 Q4 | 25.98 Million EUR | 0.0% |
2013 FY | 25.98 Million EUR | 38.99% |
2013 Q2 | 14.39 Million EUR | 0.0% |
2012 Q3 | -14.57 Million EUR | -162.63% |
2012 Q1 | -8.99 Million EUR | -158.49% |
2012 FY | 18.69 Million EUR | 21.49% |
2012 Q2 | 23.26 Million EUR | 358.54% |
2012 Q4 | 18.69 Million EUR | 228.28% |
2011 FY | 15.38 Million EUR | 228.5% |
2011 Q4 | 15.38 Million EUR | 0.0% |
2011 Q2 | 9.16 Million EUR | 0.0% |
2010 Q4 | 4.68 Million EUR | 0.0% |
2010 FY | 4.68 Million EUR | 1856.41% |
2009 FY | -266.65 Thousand EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Apontis Pharma AG | -20.8 Million EUR | 140.878% |
Dermapharm Holding SE | 921.66 Million EUR | 99.077% |
Evotec SE | 115.28 Million EUR | 92.625% |
MERCK Kommanditgesellschaft auf Aktien | 7.95 Billion EUR | 99.893% |
PharmaSGP Holding SE | 33.21 Million EUR | 74.398% |
SynBiotic SE | 3.59 Million EUR | -136.771% |